MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention

NCT03961334 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

620

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Ischemic

Interventions

DRUG: Dabigatran
DRUG: Apixaban
DRUG: Edoxaban
DRUG: Aspirin
DRUG: Clopidogrel

Sponsor

University of Zurich

Collaborators

[object Object]